Deals
Shire Said in Advanced Talks to Acquire Drugmaker Baxalta
- Dublin-based company may pay about $32 billion before debt
- Cash and stock offer could be announced as soon as this week
Shire Said Nearing $32 Billion Acquisition of Baxalta
This article is for subscribers only.
Shire Plc is in advanced talks to acquire Baxalta Inc. for about $32 billion in cash and stock, excluding debt, according to people familiar with the matter.
The two drugmakers may announce a deal as soon as this week, the people said, asking not to be identified as the matter isn’t public. The price being discussed is $46.50 to $48 a share, two of the people said. Final details of the transaction are still being negotiated and the timing and structure of any offer may change, they said.